Clinical Trials Browser

Recruiting × INDUSTRY × Metastatic Castration-resistant Prostate Cancer (mCRPC) × Clear all

NCT06241846 2025-08-27

A Phase II Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of YL201 in Patients With mCRPC

Phase 2 Recruiting

Metastatic Castration-resistant Prostate Cancer (mCRPC)

NCT06344715 2024-04-03

Phase 1 Study Evaluating Safety and Tolerability of SL-T10, GX-I7, and Pembrolizumab Triple Combination in mCRPC.

Phase 1 Recruiting

Metastatic Castration-resistant Prostate Cancer (mCRPC)